Back to Research Home
MDMednax Inc
Health Care · Hospital/Nursing Management · Mid
$29.29−0.88%
As of 23 Oct 2026Mkt cap $2.2B
Stage 13
AVOID
Fundamentals
30.1/75
Technical
6.0/15
Independent
36.1/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +14.1%
- 3M
- +12.1%
- 6M
- +27.1%
- 1Y
- +71.1%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 14.0xHist median 10.1x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 10.9x
- FCF yield
- 9.1%
Quality
- ROIC
- 14.3%
- Operating margin
- 0.4%
- FCF margin
- 13.2%
- Current ratio
- 1.7x
Growth
- Revenue growth
- −4.9%Latest FY YoY
- Revenue CAGR
- +0.0%
- EPS CAGR
- +6.1%
- FCF CAGR
- +54.4%
Capital
- Share-count trend
- +1.9%3Y annualised
- Net debt
- $222M0.8x OCF
Annual trend
- CAGR 2021–2025
- +0.0%
- Latest · 2025
- $2B
- YoY
- −4.9%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-10-29
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded